Hamilton Lane (NASDAQ:HLNE - Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a "sell" rating to a "hold" rating in a research note issued on Saturday.
HLNE has been the topic of a number of other research reports. Keefe, Bruyette & Woods raised their target price on Hamilton Lane from $160.00 to $168.00 and gave the company a "market perform" rating in a report on Wednesday, August 6th. Oppenheimer lowered Hamilton Lane from an "outperform" rating to a "market perform" rating in a report on Thursday, May 15th. Morgan Stanley lowered their target price on Hamilton Lane from $190.00 to $157.00 and set an "equal weight" rating on the stock in a report on Monday, April 14th. Wells Fargo & Company raised their target price on Hamilton Lane from $161.00 to $162.00 and gave the company an "equal weight" rating in a report on Friday, July 11th. Finally, JPMorgan Chase & Co. lowered their target price on Hamilton Lane from $153.00 to $145.00 and set a "neutral" rating on the stock in a report on Wednesday, July 23rd. One research analyst has rated the stock with a sell rating and seven have assigned a hold rating to the company. According to MarketBeat, Hamilton Lane has an average rating of "Hold" and a consensus price target of $163.14.
Read Our Latest Stock Analysis on HLNE
Hamilton Lane Stock Up 0.6%
Shares of NASDAQ HLNE traded up $1.03 during mid-day trading on Friday, reaching $159.70. 55,905 shares of the company traded hands, compared to its average volume of 570,380. The company has a debt-to-equity ratio of 0.29, a quick ratio of 4.32 and a current ratio of 4.32. The stock has a market cap of $8.55 billion, a PE ratio of 30.69 and a beta of 1.23. The company's fifty day moving average is $148.85 and its two-hundred day moving average is $151.63. Hamilton Lane has a fifty-two week low of $124.10 and a fifty-two week high of $203.72.
Hamilton Lane (NASDAQ:HLNE - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $1.31 EPS for the quarter, beating analysts' consensus estimates of $0.98 by $0.33. The business had revenue of $196.73 million for the quarter, compared to analyst estimates of $166.96 million. Hamilton Lane had a return on equity of 29.47% and a net margin of 30.66%. The firm's revenue for the quarter was up 11.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.47 EPS. On average, analysts expect that Hamilton Lane will post 4.97 earnings per share for the current year.
Institutional Trading of Hamilton Lane
Hedge funds have recently modified their holdings of the company. Kayne Anderson Rudnick Investment Management LLC bought a new position in shares of Hamilton Lane during the 1st quarter worth approximately $432,772,000. Wellington Management Group LLP lifted its position in shares of Hamilton Lane by 5.5% during the 1st quarter. Wellington Management Group LLP now owns 1,701,963 shares of the company's stock worth $253,031,000 after buying an additional 88,100 shares during the period. Price T Rowe Associates Inc. MD lifted its position in shares of Hamilton Lane by 5.9% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 1,368,373 shares of the company's stock worth $203,437,000 after buying an additional 76,107 shares during the period. T. Rowe Price Investment Management Inc. lifted its position in shares of Hamilton Lane by 63.4% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 1,275,000 shares of the company's stock worth $189,555,000 after buying an additional 494,637 shares during the period. Finally, Champlain Investment Partners LLC lifted its position in shares of Hamilton Lane by 36.7% during the 2nd quarter. Champlain Investment Partners LLC now owns 1,037,943 shares of the company's stock worth $147,512,000 after buying an additional 278,630 shares during the period. Institutional investors own 97.40% of the company's stock.
Hamilton Lane Company Profile
(
Get Free Report)
Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.
Recommended Stories

Before you consider Hamilton Lane, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hamilton Lane wasn't on the list.
While Hamilton Lane currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.